The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Compounded "semaglutide" is not FDA approved semaglutide.com The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner